Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-5 of 5 for your search:
Drug:
clodronate disodium
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Clodronate for Locally Advanced Adenocarcinoma of the Prostate
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
over 18
Sponsor:
Protocol IDs:
MRC-PR04
, EU-94032
2.
Phase III Randomized Double-Blind Study of Clodronate vs Placebo in Patients with Prostate Cancer Metastatic to Bone Who Are Commencing or Responding to Initial Hormone Therapy (Summary Last Modified 03/1999)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
any age
Sponsor:
Protocol IDs:
MRC-PR05
, EU-94033
3.
Phase III Randomized Study of Mitoxantrone and Prednisone With or Without Clodronate in Patients with Hormone Refractory Metastatic Prostate Cancer and Pain
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Closed
Age:
Any age
Sponsor:
Protocol IDs:
CAN-NCIC-PR6
, NCT00003232, PR6
4.
Phase III Randomized Study of Adjuvant Clodronate With or Without Systemic Chemotherapy and/or Hormonal Therapy in Women With Early Stage Breast Cancer
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
Not specified
Sponsor:
NCI
Protocol IDs:
NSABP-B-34
, SWOG-NSABP-B-34, NCCTG-NSABP-B-34, NCT00009945
5.
Phase III Randomized Study of Clodronate vs Placebo during Initial Therapy with DOX/BCNU/CTX/L-PAM (ABCM) in Patients with Previously Untreated Multiple Myeloma and of IFN-A Maintenance Therapy vs No Maintenance During First Plateau
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Closed
Age:
under 75
Sponsor:
Protocol IDs:
MRC-LEUK-MYEL-INF
, EU-92025
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute